Pfizer Stock Options Expiring on 10th of January 2025

PFE Stock  USD 25.57  0.53  2.03%   
Pfizer's latest option contracts expiring on 2025-01-10 are carrying combined implied volatility of 0.08 with a put-to-call open interest ratio of 0.0 over 19 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2025-01-10. The total put volume is at 253, with calls trading at the volume of 253. This yields a 0.41 put-to-call volume ratio.
Pfizer's stock options are financial instruments that give investors the right to buy or sell shares of Pfizer Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Pfizer stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Pfizer's stock price goes up or down, the stock options follow.
At present, Pfizer's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. Sale Purchase Of Stock is expected to grow at the current pace this year, whereas Other Stockholder Equity is projected to grow to (20.8 B).

Pfizer Inc In The Money Call Balance

When Pfizer's strike price is surpassing the current stock price, the option contract against Pfizer Inc stock is said to be in the money. When it comes to buying Pfizer's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Pfizer Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Pfizer Current Options Market Mood

Pfizer's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Pfizer Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Pfizer's options investors are not very successful. Pfizer's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Pfizer contract

Base on the Rule 16, the options market is currently suggesting that Pfizer Inc will have an average daily up or down price movement of about 0.005294% per day over the life of the 2025-01-10 option contract. With Pfizer trading at USD 25.57, that is roughly USD 0.001354. If you think that the market is fully incorporating Pfizer's daily price movement you should consider buying Pfizer Inc options at the current volatility level of 0.0847%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Pfizer Option Chain

When Pfizer's strike price is surpassing the current stock price, the option contract against Pfizer Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Pfizer's option chain is a display of a range of information that helps investors for ways to trade options on Pfizer. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Pfizer. It also shows strike prices and maturity days for a Pfizer against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntExpirationCurrent SpreadLast Price
Call
PFE Option Call 10-01-2025 1502025-01-100.0 - 0.011.41In
Call
PFE Option Call 10-01-2025 1802025-01-100.0 - 0.07.75In
Call
PFE Option Call 10-01-2025 2302025-01-100.0 - 0.02.99In
Call
PFE Option Call 10-01-2025 2502025-01-100.0 - 0.01.2In
Call
PFE Option Call 10-01-2025 2602025-01-100.0 - 0.00.7Out
Call
PFE Option Call 10-01-2025 2702025-01-100.0 - 0.00.34Out
Call
PFE Option Call 10-01-2025 2802025-01-100.0 - 0.00.15Out
Call
PFE Option Call 10-01-2025 2902025-01-100.0 - 0.00.09Out
Call
PFE Option Call 10-01-2025 3002025-01-100.0 - 0.00.05Out
Call
PFE Option Call 10-01-2025 3602025-01-100.0 - 0.00.02Out
 Put
PFE Option Put 10-01-2025 1502025-01-100.0 - 0.00.01Out
 Put
PFE Option Put 10-01-2025 2102025-01-100.0 - 0.00.04Out
 Put
PFE Option Put 10-01-2025 2202025-01-100.0 - 0.00.05Out
 Put
PFE Option Put 10-01-2025 2302025-01-100.0 - 0.00.08Out
 Put
PFE Option Put 10-01-2025 2402025-01-100.0 - 0.00.24Out
 Put
PFE Option Put 10-01-2025 2502025-01-100.0 - 0.00.57Out
 Put
PFE Option Put 10-01-2025 2602025-01-100.0 - 0.01.01In
 Put
PFE Option Put 10-01-2025 2702025-01-100.0 - 0.01.06In
 Put
PFE Option Put 10-01-2025 2802025-01-100.0 - 0.02.51In

Pfizer Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Pfizer Total Stockholder Equity

Total Stockholder Equity

46.93 Billion

At present, Pfizer's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Pfizer Corporate Directors

Helen HobbsIndependent DirectorProfile
Shantanu NarayenLead Independent DirectorProfile
James SmithIndependent DirectorProfile
Susan DesmondHellmannIndependent DirectorProfile
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Dividend Share
1.67
Earnings Share
0.75
Revenue Per Share
10.493
Quarterly Revenue Growth
0.312
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.